Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s12185-017-2364-4
Published Online: 2017-11-15
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schroeder, Thomas
Rautenberg, Christina
Haas, Rainer
Germing, Ulrich
Kobbe, Guido
License valid from 2017-11-15